CG
PTX

Cutler Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Cutler Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-369
Closed -$1.61K – 7694
2017
Q1 		$1K Buy
369
+15
+4% +$47 ﹤0.01% 6226
2016
Q4 		$0 Buy
354
+1
+0.3% +$4 ﹤0.01% 7995
2016
Q3 		$2K Hold
353
– – ﹤0.01% 5956
2016
Q2 		$1K Hold
353
– – ﹤0.01% 6488
2016
Q1 		$3K Hold
353
– – ﹤0.01% 5447
2015
Q4 		$10K Buy
+353
New +$10.7K ﹤0.01% 4201

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's PTX Position: Q2 2017 in Review

Cutler Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2017, closing a stake of 369 shares — an estimated $1.61K sold.

Cutler Group first reported a position in PTX in Q4 2015 and held it in 6 quarters. The position peaked at $10K in Q4 2015. 30 funds tracked by Wall St. Rank hold PTX as of Q2 2017.

  • Cutler Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • Cutler Group sold 369 Pernix Therapeutics Holdings, Inc. shares in Q2 2017, an estimated $1.61K.
  • Cutler Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Pernix Therapeutics Holdings, Inc. position peaked at $10K in Q4 2015.
  • 30 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.